8-K - OS Therapies Incorporated | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

OS Therapies filed a prospectus supplement for the resale of up to 10,529,417 shares of common stock by selling stockholders, covering shares issuable upon warrant exercise and note conversion.

Key Takeaways

1The filing covers the resale of 10,529,417 shares of common stock by selling stockholders.

2The shares consist of 4,289,441 Warrant Shares and 6,239,976 Conversion Shares.

3The prospectus supplement relates to an effective S-3 registration statement filed on August 8, 2025.

4The Company received requisite approval from NYSE American to list the Warrant Shares and Conversion Shares.

5Olshan Frome Wolosky LLP provided a legal opinion confirming the validity of the shares.

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

.** **Other Events.** On March 31, 2026, OS Therapies Incorporated (the “Company”) filed with the U.S. Securities and Exchange Commission (the “SEC”) a prospect

Other Event

9.01

Financial Statements and Exhibits.** (d) Exhibits. | Exhibit Number | | Description | |---|---|---| | 5.1 | | Opinion of Olshan Frome Wolosky LLP. | | 23.1 | |

Exhibits Only

Exhibits (2)

5.1

OPINION OF OLSHAN FROME WOLOSKY LLP

8-K

CURRENT REPORT